Should topical imiquimod be used for positive margins in lentigo maligna?

J Am Acad Dermatol. 2021 Aug;85(2):521-522. doi: 10.1016/j.jaad.2020.02.087. Epub 2020 May 7.

Authors

Timothy S Wang¹, Caitlin C Griffiths², Elise M Roman³

Affiliations

¹ Lakeshore Dermatology, Norton Shores, Norton Shores, Michigan. Electronic address: tw0842@yahoo.com.
² UCL Medical School, University College London, London, United Kingdom.
³ University of Toledo College of Medicine, Toledo, Ohio.

PMID: 32387661
DOI: 10.1016/j.jaad.2020.02.087

No abstract available

MeSH terms

Administration, Topical
Antineoplastic Agents / administration & dosage*
Humans
Hutchinson's Melanotic Freckle / drug therapy*
Hutchinson's Melanotic Freckle / pathology*
Hutchinson's Melanotic Freckle / surgery
Imiquimod / administration & dosage*
Margins of Excision*
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology*
Skin Neoplasms / surgery

Substances

Antineoplastic Agents
Imiquimod